GSK097
GSK097 is a potent and selective Inhibitor of the second bromodomain (BD2) of the bromodomain and extra-terminal domain (BET) proteins. GSK097 displays 2000-fold selective for BD2 over BD1 (BRD4 data) with >1 mg/mL solubility in FaSSIF media[1].
Product Specifications
CAS Number
2159137-02-5
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk097.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=NC([C@@H](O)C2=CC=CC=C2)=CC(C(N[C@@H]3[C@@H](C)C3)=O)=C1)NC
Molecular Formula
C19H21N3O3
Molecular Weight
339.39
References & Citations
[1]Harrison LA, et al. Identification of a Series of N-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) Proteins [published online ahead of print, 2021 Jul 7]. J Med Chem. 2021;10.1021/acs.jmedchem.0c02155.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
